Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine.

In an attempt to induce an immune response against tumour antigens, several groups are transfecting cytokine and other genes into autologous tumour cells which are given to the patient as a vaccine. This process is labour-intensive, time-consuming and expensive. Allogeneic cells would offer a more c